HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer.

Purpose: New generation of receptor tyrosine kinase inhibitors (RTKIs) have shown to improve survival in many solid tumors. However, an imaging biomarker is needed for patient selection and prediction of treatment response. This study evaluates the use of quantitative changes of HER3 on 68 Ga-NOTA-H...

Full description

Bibliographic Details

Published in:	Molecular Imaging & Biology Vol. 25; no. 2; pp. 353 - 363
Main Authors:	Esfahani, Shadi A., de Aguiar Ferreira, Carolina, Rotile, Nicholas J., Ataeinia, Bahar, Krishna, Shriya, Catalano, Onofrio A., Caravan, Peter, Yen, Yi-Fen, Heidari, Pedram, Mahmood, Umar
Format:	Journal Article
Published:	Springer Nature Apr2023
Online Access:	View this record in EBSCOhost